The Promise of Precision Medicine

With next-generation sequencing and CAR-T therapy entering the market, the age of precision medicine is upon us. How will individualized treatment revolutionize healthcare as we know it?

Dimensions to be addressed:
- Globalizing access and affordability
- Redesigning data governance
- Navigating ethical complexities

· Nancy Brown, Chief Executive Officer, American Heart Association, USA
· Jay Flatley, Executive Chairman, Illumina, USA
· Scott Gottlieb, Commissioner, United States Food & Drug Administration
· Vasant Narasimhan, Global Head, Drug Development; Chief Executive Officer-designate, Novartis Pharma, Switzerland
· Tan Chorh Chuan, Executive Director, Office for Healthcare Transformation, Ministry of Health of Singapore

Moderated by
· Linda Pizzuti Henry, Managing Director, Boston Globe, USA